167 related articles for article (PubMed ID: 178605)
1. Antinuclear antibodies and elevated anti-Epstein-Barr virus titers in cancer patients.
McCormick NK; McCormick KJ; Trentin JJ
Infect Immun; 1976 May; 13(5):1382-6. PubMed ID: 178605
[TBL] [Abstract][Full Text] [Related]
2. Cytotoxic antibodies to cultured lymphoblasts unrelated to Epstein-Barr virus.
Yang CS; Hewetson JF
Int J Cancer; 1974 Oct; 14(4):530-8. PubMed ID: 4376526
[No Abstract] [Full Text] [Related]
3. Epstein-Barr virus-related serology in Hodgkin's disease.
Henle W; Henle G
Natl Cancer Inst Monogr; 1973 May; 36():79-84. PubMed ID: 4355353
[No Abstract] [Full Text] [Related]
4. Antibody to the rheumatoid arthritis nuclear antigen. Its relationship to in vivo Epstein-Barr virus infection.
Catalano MA; Carson DA; Niederman JC; Feorino P; Vaughan JH
J Clin Invest; 1980 May; 65(5):1238-42. PubMed ID: 6245108
[TBL] [Abstract][Full Text] [Related]
5. Epstein-Barr virus-specific IgA serum antibodies as an outstanding feature of nasopharyngeal carcinoma.
Henle G; Henle W
Int J Cancer; 1976 Jan; 17(1):1-7. PubMed ID: 175020
[TBL] [Abstract][Full Text] [Related]
6. Occurrence of Epstein-Barr virus deoxyribonuclease enzyme activity-neutralizing antibodies. An index of Epstein-Barr virus disease.
Bardy B; Morinet F; Pérol Y
Intervirology; 1989; 30(1):36-43. PubMed ID: 2542178
[TBL] [Abstract][Full Text] [Related]
7. Specific neutralizing antibodies in Epstein-Barr virus associated diseases.
Rocchi G; Hewetson J; Henle W
Int J Cancer; 1973 May; 11(3):637-47. PubMed ID: 4364719
[No Abstract] [Full Text] [Related]
8. [Demonstration of IgG- and IgA-antibodies against Epstein-Barr virus-associated antigens with a microtiter enzyme immunoassay system. The determination of serum antibodies against the viral capsid antigen and the early antigen complex in the sera of tumor and infectious mononucleosis patients].
Dölken G; Bitzer M; Bross KJ; Brugger W; Boldt C; Hirsch FW; Weitzmann U; Löhr GW
Dtsch Med Wochenschr; 1984 Nov; 109(48):1837-43. PubMed ID: 6094138
[TBL] [Abstract][Full Text] [Related]
9. Epstein-Barr virus-specific IgM in infectious mononucleosis, Burkitt lymphoma, nasopharyngeal carcinoma.
Banatvala JE; Best JM; Waller DK
Lancet; 1972 Jun; 1(7762):1205-8. PubMed ID: 4113190
[No Abstract] [Full Text] [Related]
10. [Elevated Epstein-Barr virus antibodies in patients with Hodgkin's disease].
Kuljić-Kapulica N
Srp Arh Celok Lek; 1998; 126(3-4):97-100. PubMed ID: 9863363
[TBL] [Abstract][Full Text] [Related]
11. [Immunology of Epstein-Barr virus in lymphoproliferative diseases].
Bachmann AE; Giraudo Conesa LC; Braun M
Medicina (B Aires); 1974 Mar; 34(2):157-66. PubMed ID: 4368156
[No Abstract] [Full Text] [Related]
12. [Epstein-Barr virus infection in children: study of infectious mononucleosis without heterophil antibodies].
Baccard C; François P; Bost M; Bachelot C; Decret M; Beaudoing A; Seigneurin JM
Ann Pediatr (Paris); 1983 Jun; 30(6):416-21. PubMed ID: 6309061
[No Abstract] [Full Text] [Related]
13. Humoral antibodies to the capsid antigen of Epstein-Barr virus in Hodgkin's disease.
Stepina VN; Gourtsevicz VE; Mazurenko NP; Yarymova NM; Kaverznyeva MM; Lorye YI
Neoplasma; 1976; 23(5):523-32. PubMed ID: 185535
[TBL] [Abstract][Full Text] [Related]
14. Detection of Epstein-Barr virus antigens and antibodies by peroxidase-labeled specific immunoglobulins.
Kurstak E; de Thé G; van den Hurk J; Charpentier G; Kurstak C; Tijssen P; Morisset R
J Med Virol; 1978; 2(3):189-200. PubMed ID: 212523
[TBL] [Abstract][Full Text] [Related]
15. [A comparison of the detection of IgM antibodies against the viral capsid antigen (VCA) of EBV (Epstein-Barr virus) in various groups of patients, using indirect immunofluorescence, indirect ELISA and reverse ELISA. Study of the diagnostic efficacy of the anti-VCA EBV IgM ELISA-VIDITEST kit].
Pumannová M; Rezbová M; Svecová M; Hrbácková H; Novotná M; Ochotná J; Roubalová K
Klin Mikrobiol Infekc Lek; 2004 Aug; 10(4):186-90. PubMed ID: 15328576
[TBL] [Abstract][Full Text] [Related]
16. Restricted low-level human antibody responses against Epstein-Barr virus (EBV)-encoded latent membrane protein 1 in a subgroup of patients with EBV-associated diseases.
Meij P; Vervoort MB; Aarbiou J; van Dissel P; Brink A; Bloemena E; Meijer CJ; Middeldorp JM
J Infect Dis; 1999 May; 179(5):1108-15. PubMed ID: 10191211
[TBL] [Abstract][Full Text] [Related]
17. Serum IgA antibodies of Epstein-Barr virus (EBV)-related antigens. A new feature of nasopharyngeal carcinoma.
Henle G; Henle W
Bibl Haematol; 1975 Oct; (43):322-5. PubMed ID: 183692
[No Abstract] [Full Text] [Related]
18. Relation between neutralization of Epstein-Barr virus and antibodies to cell-membrane antigens-induced by the virus.
Pearson G; Dewey F; Klein G; Henle G; Henle W
J Natl Cancer Inst; 1970 Nov; 45(5):989-95. PubMed ID: 18605425
[TBL] [Abstract][Full Text] [Related]
19. Antibody patterns in different human sera against intracellular and membrane-antigen complexes associated with Epstein-Barr virus.
Svedmyr A; Demissie A; Klein G; Clifford P
J Natl Cancer Inst; 1970 Mar; 44(3):595-610. PubMed ID: 11515428
[No Abstract] [Full Text] [Related]
20. Epstein-Barr virus in human disease.
Langenhuysen MM; The TH
Neth J Med; 1973; 16(2):85-93. PubMed ID: 4350284
[No Abstract] [Full Text] [Related]
[Next] [New Search]